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In cultured cells, infection by group B coxsackievirus
(CVB) is mediated by the coxsackievirus and adeno-
virus receptor (CAR), but the importance of this
molecule in CVB-induced disease has not been
determined. We generated mice with tissue-specific
ablation of CAR within each of two major CVB target
organs, the pancreas and heart. In the pancreas,
deletion of CAR resulted in a significant reduction in
both virus titers and virus-induced tissue damage.
Similarly, cardiomyocyte-specific CAR deletion re-
sulted in a marked reduction in virus titer, infection-
associated cytokine production, and histopathology
within the heart. Consistent with the in vivo pheno-
type, CAR-deficient cardiomyocytes resisted infec-
tion in vitro. These results demonstrate a critical func-
tion for CAR in the pathogenesis of CVB infection
in vivo and in virus tropism for the heart andpancreas.
INTRODUCTION
Receptors have been identified for many of the viruses that
cause human disease (Dermody and Tyler, 2005), but our current
understanding of their function is based almost entirely on work
performed in cultured cells. Further, many viruses are known to
interact with multiple receptors in vitro (Helenius, 2007), yet it is
unclear how viruses use alternative receptors in the course of
infection and uncertain whether specific identified receptors
contribute to in vivo tropism. Several recent observations under-
score the importance of extending receptor studies to in vivo
models. The marked tropism of adenovirus for the liver has
been found to involve none of the identified adenovirus recep-
tors, resulting instead from a complex interaction with coagula-
tion factors and unidentified hepatocyte molecules (Kalyuzhniy
et al., 2008; Waddington et al., 2008). Measles virus entry into
the body, which had formerly been postulated to involve virusinfection of airway epithelial cells, has been shown not to require
virus interaction with its epithelial cell receptor (Leonard et al.,
2008), and the major reovirus receptor, JAM-A, proves to be
dispensable for direct infection of target tissues but important
for hematogenous spread of virus from its primary site of replica-
tion in the intestinal epithelium (Antar et al., 2009).
We have now tested the function of the coxsackievirus and
adenovirus receptor (CAR) (reviewed in Bergelson, 2002) in a
well-characterized mouse model of myocarditis and pancreatitis
caused by group B coxsackieviruses (CVBs) (Huber and Ram-
singh, 2004; Woodruff, 1980). CVBs are common human patho-
gens that cause febrile illnesses as well as diseases of the heart,
pancreas, and central nervous system (Modlin, 1995). They are
among the major causes of viral myocarditis (Bowles et al.,
2003), and they are implicated as a cause of dilated cardiomyop-
athy (Martino et al., 1994), one of the most common indications
for cardiac transplantation. CVBs also cause pancreatitis, and
although the association remains controversial, they are thought
to contribute to the pathogenesis of childhood-onset diabetes
(Drescher and Tracy, 2008).
In cultured cells, CVBs have been found to interact with at
least three receptors. All tested clinical and laboratory isolates
bind to CAR, a 46 kDa adhesion molecule, and attachment to
CAR on transfected rodent cells is sufficient for infection (Bergel-
son, 2002). A large subset of CVB isolates also bind to decay-
accelerating factor (DAF), a complement regulatory protein,
and DAF-induced intracellular signals are required for infection
of polarized epithelial cells (Coyne and Bergelson, 2006). In addi-
tion, at least one CVB3 isolate has been shown to use a third
receptor, heparan sulfate, to infect CAR-deficient cells in vitro
(Zautner et al., 2003). Each of these receptors is expressed on
a variety of cell types in vivo, but their importance in pathogen-
esis has not been tested.
To investigate CAR’s role in the pathogenesis of CVB3 pancre-
atitis and myocarditis, we used tissue-specific gene deletion to
ablate CAR expression specifically within the pancreas or the
heart. We found that, during infection, virus titers in CAR-defi-
cient tissues were markedly reduced, as were virus-induced
tissue destruction and inflammation. The results demonstrateCell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc. 91
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esis and tropism in vivo. In addition, they support the idea that
tissue damage and inflammation depend on high titer virus repli-
cation within target tissues.
RESULTS
Tissue-Specific CAR Gene Deletion
CAR is essential for normal embryonic development, and CAR
null mice do not survive beyond day 11 of embryonic life (Asher
et al., 2005; Chen et al., 2006; Dorner et al., 2005). To obtain
CAR-deficient mice, we used Cre-loxP technology to achieve
tissue-specific deletion of the CAR gene in mice that survive
into adulthood. We previously reported the generation of mice
in which exon 2 of the CAR gene is flanked by recognition sites
(loxP) for Cre DNA recombinase (‘‘floxed’’) (Chen et al., 2006).
Cre-mediated deletion of exon 2 results in a frame shift and
premature termination within the CAR leader sequence, creating
a null allele. To ablate CAR expression within the pancreas, we
bred CAR-floxed mice to transgenic mice expressing Cre under
the control of the pancreas-specific pancreas duodenal
homeobox gene 1 (pdx) promoter (Gu et al., 2002). To target
CAR expression within the heart, we bred CAR-floxed mice to
mice expressing Cre under the control of the cardiomyocyte-
specific a-myosin heavy chain (MHC) promoter (Gaussin et al.,
2002). In all experiments, mice were of mixed genetic back-
ground (129/Sv and C57BL/6), and knockout animals were
matched to littermate controls.
As determined by quantitative DNA PCR, CAR gene deletion in
the heart (40%, SEM ± 7% in 8 animals examined) was less
extensive than it was in the pancreas (75%, SEM ± 3% in 28
animals), perhaps because the a-MHC promoter is active only
in the cardiomyocyte population within the heart. However, as
measured by quantitative RNA PCR, expression of functional
CAR mRNA was reduced in the heart by 97% (Figure S1A), sug-
gesting that cardiomyocytes are the predominant CAR-express-
ing cell type; CAR mRNA in the pancreas was reduced by 94%.
Consistent with this, immunoblot analysis and indirect immuno-
fluorescence revealed that CAR protein levels were markedly
reduced in the Panc-KO pancreas (Figures S1B and S1C) and
in the Hrt-KO heart (Figures S1D and S1E). Given the insensitivity
of immunoblots, we cannot exclude the persistence of CAR
protein at the low but measurable levels observed for CAR
mRNA. As expected, CAR expression levels in the livers of
Panc- and Hrt-KO mice were the same as those in controls.
Pancreatic CAR Deletion Attenuates Pancreatic
Infection and Pancreatitis
To identify the role of CAR in CVB infection of the pancreas, we
infected Panc-KO and littermate control mice with CVB3-H3,
a strain known to cause both myocarditis (Van Houten et al.,
1991) and pancreatitis (Mena et al., 2000). During the acute phase
of infection, mice become hypoglycemic, most likely as a result of
pancreatitis and digestive dysfunction (Mena et al., 2000). Base-
line blood glucose levels were equivalent in uninfected Panc-KO
and control mice (Figure 1A). However, by the second day of
infection, control mice showed the expected drop in blood
glucose levels, whereas Panc-KO animals remained normogly-
cemic, suggesting that they were protected from pancreatitis.92 Cell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc.Mice were sacrificed 6 days after infection (the peak of replica-
tion, as determined in preliminary experiments), and virus titers in
the pancreas and heart were measured by plaque assay.
Pancreatic titers in Panc-KO mice were more than 1000-fold
lower than those in controls, with titers in some samples below
the limits of detection (Figure 1B); titers in the heart were reduced
less than 10-fold, although the difference was statistically signif-
icant. To confirm these results, we examined a larger number of
mice in three independent experiments, examining titers in
multiple tissues at both 6 and 8 days after infection (Figure 1C):
titers in the pancreas of Panc-KO mice were consistently lower
than those in controls, and no differences were seen in titers
from the heart and liver. In the spleens, titers were similar on
day 6, but for unclear reasons Panc-KO spleens had lower titers
than controls on day 8. Together, these results confirm that the
Panc-KO mice are protected from viral infection of the pancreas
and suggest that the titer of virus within the pancreas has little
effect on the titers found in other organs.
Histologic evaluation revealed that infected control mice had
severe pancreatitis, with destruction of the acinar tissue, inflam-
matory cell infiltration, and ductal proliferation; in contrast, Panc-
KO mice exhibited only mild inflammation and little tissue damage
(Figures 1D and 1E). Both Panc-KO and control mice developed
chemical pancreatitis after exposure to caerulein (Lampel and
Kern, 1977), demonstrating that protection of Panc-KO mice
was virus specific (Figure S2). Taken together, these experiments
show that CAR expression is important for virus infection of the
pancreas and for the initiation of viral pancreatitis.
Cardiomyocyte-Specific CAR Deletion Attenuates
Cardiac Infection and Myocarditis
We infected Hrt-KO and littermate controls with CVB3-H3 and
measured virus titers in the heart and pancreas at day 7 after
infection. Heart titers in Hrt-KO mice were more than 100-fold
lower than those in controls (Figure 2A); titers in the pancreas
were similar in Hrt-KO and control mice. Similar results were
obtained when we examined titers in multiple tissues over
a time course of infection (Figure 2B). Titers in the hearts of
Hrt-KO mice were consistently lower than those in controls,
whereas titers in the liver and spleen were similar in Hrt-KO
and control animals; a slight reduction of titer in the pancreas
of Hrt-KO animals was observed at day 7 in this experiment,
but not in an additional experiment involving five knockout and
five control animals (data not shown). Histologic examination
of heart sections 7 days postinfection revealed that control
mice suffered both inflammation and cardiomyocyte necrosis,
whereas Hrt-KO mice showed little inflammation and no
evidence of necrosis (Figures 2C and 2D).
We used quantitative RT-PCR to examine expression of cyto-
kines and chemokines that are known to be upregulated in the
hearts of mice with CVB3 myocarditis and are believed to be
important in regulation of the inflammatory response (Figure 2E).
In control mice, as expected, we saw increased expression of
IL-6 (Seko et al., 1997), IL-10 (Seko et al., 1997), MCP-1 (Shen
et al., 2004), IP-10 (Weinzierl et al., 2008), IFNb (Schmidtke
et al., 2000), and IFNg (Seko et al., 1997). In Hrt-KO mice, IFNb
and IFNg were induced to the levels seen in control mice, but
induction of IL-10 and IP-10 was attenuated, and there was no
induction of IL-6 or MCP-1. These results suggest that, in
Cell Host & Microbe
CAR in Myocarditis and PancreatitisFigure 1. Reduced Virus Titers and Pancreatitis in Infected Panc-KO Mice
(A) Mice were infected with 1 3 105 pfu/mouse of CVB3-H3, and blood glucose levels were measured daily. Error bars indicate SEM.
(B) After 6 days, virus titers in pancreas and heart were determined by plaque assay. Each symbol represents the virus titer (pfu per gram of tissue) from an indi-
vidual mouse. Means for each experimental group are indicated by horizontal black lines (n = 8–9 for each genotype).
(C) Virus titers in mice infected with 13 103 pfu/mouse of CVB3-H3. Titers combined from three separate experiments (n = 12–14 for each experimental group) are
shown: the colored box encloses the 25th–75th percentiles, the mean is depicted as a line, and the range for the entire group is shown as bars. Shaded regions
represent the lower limits of viral detection.
(D) Pancreas sections stained with H&E. Infected tissues were examined 6 days after infection with 1 3 105 pfu/mouse. Scale bars, 80 microns.
(E) Severity scores for pancreatitis and myocarditis (day 6) in control (n = 8) and Panc-KO (n = 9) mice, determined as described in Experimental Procedures. Error
bars indicate SEM. Asterisks indicate a statistically significant difference between the Panc-KO and control groups by Student’s t test (*p < 0.05; **p < 0.005).many cases, cytokine induction depends on high titer virus repli-
cation within cardiomyocytes.
Isolated Hrt-KO Cardiomyocytes Are Protected
from Infection In Vitro
Although virus titers in Hrt-KO hearts were much lower than
those in controls, some residual virus was detected. This could
result from incomplete CAR deletion in the cardiomyocyte
population, infection of noncardiomyocyte cell types, or infection
of cardiomyocytes by a CAR-independent mechanism. To inves-
tigate these possibilities, we isolated and cultured primary cells
from the hearts of newborn knockout and littermate control
mice. Cultured cells were stained for sarcomeric myosin, a cardi-
omyocyte-specific marker, and for CAR (Figure 3A). In control
cultures, all cardiomyocytes were seen to express CAR; among
the noncardiomyocyte population, we observed both CAR-posi-
tive and CAR-negative cells (top row). In Hrt-KO cultures, cardi-
omyocytes did not express CAR, and CAR staining was limited
to a minority of cells that did not express the cardiomyocyte
marker (bottom row).To determine whether cardiomyocytes can be infected in a
CAR-independent manner, we exposed primary cultures to
CVB3-H3 and identified infected cells by staining for viral protein
(Figure 3B). In control cultures, many cells became infected;
most infected cells were cardiomyocytes, although a few were
noncardiomyocytes (top row). In the Hrt-KO cultures, very few
cells (and virtually no cardiomyocytes) were infected (bottom
row). Quantification of infected cells confirmed that the Hrt-KO
cardiomyocytes were unable to support infection, whereas
both Hrt-KO and control noncardiomyocytes were infected to
similar levels (Figure 3C); virus titers were lower in cultures
from Hrt-KO animals (Figure 3D). These observations show
that CAR is essential for CVB3 infection of cardiomyocytes. In
addition, they indicate that, within the heart, there is a population
of noncardiomyocytes that expresses CAR and is potentially
susceptible to infection. Taken together with the observation
that Hrt-KO mice are protected from myocarditis, the results
with primary heart cultures confirm that virus infection of cardio-
myocytes is specifically required for the pathogenesis of acute
myocarditis.Cell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc. 93
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CAR in Myocarditis and PancreatitisFigure 2. Reduced Virus Titers and Myocarditis in Hrt-KO Mice
(A) Mice were infected with 13 105 pfu/mouse of CVB3-H3 and sacrificed 7 days postinfection. Each symbol represents the titer (pfu per gram of tissue) from an
individual mouse. Means for each experimental group are indicated by horizontal black lines (n = 8 for each genotype).
(B) Serial titers in mice infected with 1 3 105 pfu (n = 3–5 mice per experimental group).
(C) H&E (top) and Masson’s Trichrome stain (bottom) of heart tissue sections. Uninfected samples are shown in the left-hand panels; sections from infected mice
(day 7) are shown on the right. Scale bars, 80 microns.
(D) Severity scores for myocarditis and pancreatitis in control (n = 8) and Hrt-KO mice (n = 8), assessed as described in Experimental Procedures.
(E) Differential induction of cytokine and chemokine expression in heart tissue 7 days postinfection (13 105 pfu), measured by quantitative RNA PCR. Expression
is measured relative to uninfected control mice of the same genotype. Error bars are SEM, and asterisks indicate a statistical difference between the Hrt-KO and
controls (*p < 0.05; **p < 0.005; #p = 0.058).94 Cell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc.
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CAR in Myocarditis and PancreatitisFigure 3. CAR-Deficient Cardiomyocytes Resist Infection In Vitro
(A) Primary cardiomyocytes were isolated, and expression of CAR (green) and the cardiomyocyte-specific marker sarcomeric myosin (red) was detected by indi-
rect immunofluorescence. Cell nuclei were stained with DAPI (blue). Top panels show a representative field of cardiac cells isolated from control hearts; most
CAR-positive cells express the cardiomyocyte marker. Bottom panels show an unusual field of Hrt-KO cardiac cells with some CAR-positive cells; note that these
CAR-positive cells do not express the cardiomyocyte marker. Scale bars, 20 microns.
(B) CAR-negative cardiomyocytes are protected from coxsackievirus infection. Primary cardiomyocyte cultures were infected with CVB3-H3 (10 pfu/cell) for
48 hr. Expression of viral protein (green) and the cardiomyocyte-specific marker sarcomeric myosin (red) was detected by indirect immunofluorescence. Top
panels show a representative field of cardiomyocytes isolated from control hearts; most of the virus-infected cells are cardiomyocytes. Lower panels show a field
of Hrt-KO cardiomyocytes that contains virus-infected cells (most of the fields have no infected cells); note that the virus-infected Hrt-KO cells do not express the
cardiomyocyte marker. Scale bars, 20 microns.
(C) Total numbers of virus-infected cardiomyocytes and noncardiomyocytes.
(D) Virus titers produced by infected cardiac cells (mean ± SEM for triplicate wells; **p < 0.005).DISCUSSION
The experiments reported here indicate that CAR is the major
receptor mediating CVB infection of the pancreas and heartin vivo and that CAR is important for the pathogenesis of virus-
induced pancreatitis and myocarditis. Specific deletion of CAR
from the pancreas resulted in a 1000-fold reduction in virus titers
within the pancreas during infection and a significant reduction inCell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc. 95
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omyocyte-specific CAR deletion resulted in a 100-fold reduction
in virus titer within the heart and a significant reduction in the
number and size of histologic lesions.
We did observe some virus replication even in CAR-deficient
tissues. Although this may reflect the function of secondary
receptor molecules, we believe that it more likely results from
a persistence of CAR expression in target tissues. In CAR-
deleted tissues, CAR mRNA levels were reduced to approxi-
mately 5% of control levels; such low levels of protein expression
might not be detected on immunoblots, yet could easily account
for the low levels of residual infection. Cre-mediated gene dele-
tion has variable efficiency, and Cre expression is limited to
specific cell types within the target tissues. In the heart, the
a-MHC promoter drives Cre expression specifically within cardi-
omyocytes, but not in endothelial cells, fibroblasts, or other cell
types. In primary cultures of cardiac cells, we found that CAR
was expressed on a population of nonmuscle cells. However, it
was clear that CAR expression and susceptibility to infection
were virtually ablated in the cardiomyocyte population isolated
from Hrt-KO animals.
After intraperitoneal inoculation, CVB3 quickly reaches high
titers within the pancreas, and it has been suggested that the
pancreas serves as a reservoir from which virus spreads to the
heart and other tissues (Horwitz et al., 1998). We found that
reduction of virus titer in the Panc-KO pancreas was not accom-
panied by reduction in virus titer or virus-induced pathology in
the heart. In additional experiments (Figure S3), we have studied
mice in which CAR is deleted from both the heart and the
pancreas. In these dual-knockout animals, virus titers in CAR-
deleted tissues were the same as those observed in single
knockouts. We did observe reduced titers in the spleens of
Panc-KO animals at days 7 and 8 (but not day 6) and in dual
knockouts at day 7 (Figures 1 and S3). It is thus possible that,
late in the course of infection, high titers in the pancreas
contribute to viral persistence in the spleen.
The reduction in virus titer in CAR-deficient animals was
accompanied by a marked decrease in inflammatory infiltrates
and cytokine production in the heart and reduced tissue damage
and inflammation in the pancreas. These results support the idea
that, in acute myocarditis and pancreatitis, virus replication in the
heart and pancreas is essential for the pathogenesis of necrosis
and inflammation. While this paper was under review, other
investigators similarly reported an essential role for CAR in the
pathogenesis of acute myocarditis (Shi et al., 2009). In geneti-
cally susceptible mice, the resolution of acute coxsackievirus
myocarditis is followed by the onset of chronic inflammation,
which has been attributed both to viral persistence and to auto-
immunity (Esfandiarei and McManus, 2008). Chronic pancreatitis
is also observed in some experimental models (Ramsingh,
2008). It is not known whether the chronic inflammatory re-
sponse is initiated within the target organs or whether virus repli-
cation in other tissues is sufficient to induce chronic disease. It
will be interesting to determine whether, in susceptible mice,
CAR deletion protects against chronic as well as acute
pathology.
Receptors have been identified for many of the viruses that
cause human disease, but in virtually all cases, the evidence
for receptor function is based on in vitro data, and it remains96 Cell Host & Microbe 6, 91–98, July 23, 2009 ª2009 Elsevier Inc.uncertain whether interaction with these receptors explains the
tropism of virus for particular tissues. Expression of specific
receptor molecules in transgenic animals provides evidence
that these molecules can function in infection in vivo (Ren
et al., 1990). Targeted gene deletion can determine whether a
specific receptor is required for infection and pathogenesis
(Antar et al., 2009; Taylor et al., 2007). We have now used
tissue-specific gene deletion to show that CAR is important for
the pathogenesis of CVB-induced pancreatitis and myocarditis.
The Cre-loxP technology we employed makes it possible to
examine the importance of receptor expression in specific
tissues and potentially to examine the role of particular tissue





For pancreas-specific CAR deletion, heterozygous CAR-floxed mice (Chen
et al., 2006) that also carried a transgene permitting Cre expression under
control of the pdx-1 promoter (Gu et al., 2002) (CARF/+, pdx-Cre) were bred
to mice homozygous for the floxed CAR allele (CARF/F). Offspring homozygous
for floxed CAR and that inherited the pdx-Cre allele (CARF/F-pdx-Cre) were
identified by PCR-based genotyping (see Table S1 for primers) and were ex-
pected to undergo pancreas-specific CAR deletion. CARF/F littermates without
the pdx-Cre transgene were used as controls for all experiments.
We had previously generated mice with heart-specific CAR deletion
(CARF/F, MHC-Cre) (Chen et al., 2006). To obtain Hrt-KO mice for these exper-
iments, these were bred to CARF/F. Quantitative analysis of gene deletion and
mRNA expression were performed as described in the Supplemental Experi-
mental Procedures.
Animal care and use were in accordance with institutional and NIH guide-
lines and approved by the IACUC of the Children’s Hospital of Philadelphia.
Virus Propagation and Mouse Infection
CVB3-H3 (Van Houten et al., 1991) was obtained from Dr. Sally Huber (Univer-
sity of Vermont; Burlington, VT). Virus titers were determined by triplicate pla-
que assay on HeLa cells. Mice 6–8 weeks of age were infected by intraperito-
neal injection with virus in 100 ml PBS. For glucose measurements, tail-vein
blood was analyzed with a One Touch Ultra Glucometer (LifeScan; Milpitas,
CA). After euthanasia, portions of each organ were fixed in 10% formaldehyde
for histology or frozen for determination of viral titer. Organs were weighed and
then homogenized in 0.5 ml media; tissue debris was spun down, the superna-
tant was titered, and titers were normalized to tissue weight (in grams). For
statistical analysis, samples with titers below the limit of detection were as-
signed a value of 3 pfu/ml (instead of 0) before normalization.
Histology
For histology, deparaffinized sections were stained with hematoxylin and eosin
(H&E) or Masson’s Trichrome. The severity of pancreatitis was scored inde-
pendently by two pathologists (M.G. and M.D.S., who were blinded to the iden-
tity of samples) according to the following scale: 0, no inflammation; 1, mild to
moderate interstitial inflammation; 2, moderate inflammation and/or acinar
loss; 3, massive inflammation and/or necrosis; 4, massive inflammation and
multifocal ductal proliferation. The severity of myocarditis was scored as
follows: 0, no lesions; 1, one or few small lesions; 2, multiple small or few large
lesions; 3, multiple small and large lesions; 4, massive lesions. Lesions were
defined as areas of inflammation and/or cardiomyocyte necrosis and loss.
Cardiomyocyte Culture and Infection
Cardiomyocytes were isolated using a neonatal cardiomyocyte isolation kit
from Worthington Biochemical Corporation (Lakewood, NJ). In brief, pups
1–2 days old were sacrificed, and individual hearts were minced and trypsi-
nized overnight. Samples were pooled according to genotype, and isolation
Cell Host & Microbe
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were enriched by preplating two times (75 min) on uncoated tissue culture
plates to remove adherent cells. Cardiomyocytes were plated at a density of
5 3 104 cells/cm2 on collagen-coated chamber slides (BD Biosciences;
Franklin Lakes, NJ) for immunofluorescence or in collagen-coated 96-well
culture plates for determination of virus titer, in DMEM-F12 supplemented
with nonessential amino acids, penicillin-streptomycin, selenium insulin trans-
ferrin mix, and 10% FBS. Twenty-four hours later, cardiomyocytes were
exposed to virus (10 pfu/cell) for 1 hr at room temperature, then washed, given
fresh medium, and incubated at 37C for 48 hr.
Cells were fixed with cold 50% methanol-acetone for 15 min and then
washed twice with PBS before staining. Sarcomeric myosin was detected
with monoclonal antibody MF20 (dilution 1:2000, Developmental Studies
Hybridoma Bank; Iowa City, IA) and goat anti-mouse IgG2b Alexa Fluor 594
(1:500, Invitrogen). Virus was detected with monoclonal anti-enterovirus VP1
(dilution 1:50, NCL-ENTERO, Leica Microsystems; Bannockburn, IL) and
goat anti-mouse IgG2a Alexa Fluor 488 (1:500, Invitrogen); CAR was detected
with polyclonal rabbit anti-CAR (1:50, H-300, Santa Cruz Biotechnology; Santa
Cruz, CA) and goat anti-rabbit Alexa Fluor 488 (1:500, Invitrogen).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, one table, and three figures and can be found online at
http://www.cell.com/cell-host-microbe/supplemental/S1931-3128(09)00189-9.
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